President Trump signed an executive order on August 10, 2026, that alters the recommended childhood vaccine schedule, reducing the number of routine vaccinations from 18 to 11 and calling for the Measles, Mumps and Rubella (MMR) vaccine to be administered in three separate doses over time. The move comes as the United States faces a significant increase in measles cases and risks losing its measles elimination status.
As of August 6, 2026, the U.S. has confirmed 2,465 measles cases, surpassing the total for 2025. The nation has experienced 38 outbreaks this year, marking the highest number of cases in 35 years. This resurgence jeopardizes the measles elimination status, achieved in 2000, which signifies an absence of sustained domestic transmission for at least 12 months.
Medical professionals have expressed concern regarding the timing of the executive order. Dr. Matthew Harris, a pediatric emergency medicine attending physician with Northwell Health, noted that even children who recover from measles can suffer severe, long-term health consequences, including neurological damage, organ damage, and increased vulnerability to other infections.
The executive order refers to a new vaccine administration standard of 11 vaccines. The newly confirmed director of the Centers for Disease Control and Prevention (CDC), Dr. Erica Schwartz, has affirmed her belief that vaccines are safe and effective, though it remains unclear if her statement refers to the full CDC-recommended schedule or the revised one.
The American Academy of Pediatrics (AAP) responded to the executive order, stating that its vaccine recommendations are based on extensive research and real-world data, tailored to the health of U.S. children. The AAP emphasizes that specific vaccine ages are determined by the optimal response of a child's immune system and their vulnerability to diseases. While acknowledging that single or multiple vaccine administrations can be beneficial, the organization highlighted that its immunization schedule is supported by twelve major national health organizations and over 230 public health and medical groups.
There is no scientific evidence linking vaccines to autism. The AAP maintains that clinical decisions should be guided by science and data, allowing for discussions between practitioners and families regarding individual children's health needs and optimal vaccination schedules. The cost and insurance coverage for vaccines remain unaffected by the schedule changes, although spreading out vaccine appointments could lead to increased financial and time burdens for families and reduce the time pediatricians have with patients.
Dr. Harris stressed the importance of the medical community focusing on advocating for children's health based on scientific evidence rather than political influences, particularly during this critical public health period.